The US Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cance ...
Zacks Investment Research on MSN
ImmunityBio vs. Moderna: Which biotech has more upside potential?
Both ImmunityBio IBRX and Moderna MRNA are biotech firms that depend largely on the successful commercialization of a single ...
Healthbeat on MSN
What to know about screening for breast cancer
Breast cancer is the most common cancer among women in New York state. Every year, about 16,700 women in New York are ...
Setidegrasib exhibited durable clinical activity among pretreated patients with advanced non-small cell lung cancer, ...
The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results